Berkeley Lights Announces Collaboration with University of Pennsylvania to Advance CAR-T Therapeutics
Locus Biosciences Enters a Collaboration and License Agreement with Johnson & Johnson Innovation to develop CRISPR-Cas3 Bacteriophage Therapeutics
Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates
Intrexon and Merck KGaA, Darmstadt, Germany, Announce Agreement Realizing Precigen’s Vision for Full Developmental Autonomy of its CAR-T Program
BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD
Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines
Novo Nordisk purchases Berkeley Lights’ Beacon® Optofluidic platform for cell line development and antibody discovery
CELLINK and Prellis Biologics Inc. sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing
Berkeley Lights Launches Plasma B Cell Antibody Discovery Workflow on the Beacon® Optofluidic Platform
